Neurogene Inc. focuses on developing genetic medicines to treat rare neurological diseases, utilizing advanced technologies to potentially transform patient care.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!